Joshua Marks
Pfizer, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Real world experience from crizotinib in patients with ALK positive advanced NSCLC, from a compassionate use program run in Australia and New Zealand (#342)
3:00 PM
Justin Binko
Posters 2